Report Detail

Medical Devices & Consumables Global Medical Hemostatic Powders Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4692456
  • |
  • 11 May, 2026
  • |
  • Global
  • |
  • 115 Pages
  • |
  • GIR
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Medical Hemostatic Powders market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Medical hemostatic powder can quickly and effectively stop bleeding, and is more and more used in surgical operations and daily life.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report is a detailed and comprehensive analysis for global Medical Hemostatic Powders market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Medical Hemostatic Powders market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Hemostatic Powders market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Hemostatic Powders market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Medical Hemostatic Powders market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Medical Hemostatic Powders
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Medical Hemostatic Powders market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BD, Johnson & Johnson, Qingdao Zhonghui Health Industrial Group, Pfizer, Success Bio-Tech, Hangzhou Singclean Medical Products, Medtrade Products, Beijing Tech-Bio-Med Medical Equipment, Baxter (PerClot), BioCer Entwicklungs, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Medical Hemostatic Powders market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polysaccharide Type
Cellulose Type
Gelatin Type
Others
Market segment by Application
Hospital
Clinic
Others
Major players covered
BD
Johnson & Johnson
Qingdao Zhonghui Health Industrial Group
Pfizer
Success Bio-Tech
Hangzhou Singclean Medical Products
Medtrade Products
Beijing Tech-Bio-Med Medical Equipment
Baxter (PerClot)
BioCer Entwicklungs
Hemostasis
Qingdao Biotemed Biomaterials
Aegis Lifesciences
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Medical Hemostatic Powders product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Medical Hemostatic Powders, with price, sales quantity, revenue, and global market share of Medical Hemostatic Powders from 2021 to 2026.
Chapter 3, the Medical Hemostatic Powders competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Medical Hemostatic Powders breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Medical Hemostatic Powders market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Medical Hemostatic Powders.
Chapter 14 and 15, to describe Medical Hemostatic Powders sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Medical Hemostatic Powders Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Polysaccharide Type
    • 1.3.3 Cellulose Type
    • 1.3.4 Gelatin Type
    • 1.3.5 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Medical Hemostatic Powders Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital
    • 1.4.3 Clinic
    • 1.4.4 Others
  • 1.5 Global Medical Hemostatic Powders Market Size & Forecast
    • 1.5.1 Global Medical Hemostatic Powders Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Medical Hemostatic Powders Sales Quantity (2021-2032)
    • 1.5.3 Global Medical Hemostatic Powders Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 BD
    • 2.1.1 BD Details
    • 2.1.2 BD Major Business
    • 2.1.3 BD Medical Hemostatic Powders Product and Services
    • 2.1.4 BD Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 BD Recent Developments/Updates
  • 2.2 Johnson & Johnson
    • 2.2.1 Johnson & Johnson Details
    • 2.2.2 Johnson & Johnson Major Business
    • 2.2.3 Johnson & Johnson Medical Hemostatic Powders Product and Services
    • 2.2.4 Johnson & Johnson Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Johnson & Johnson Recent Developments/Updates
  • 2.3 Qingdao Zhonghui Health Industrial Group
    • 2.3.1 Qingdao Zhonghui Health Industrial Group Details
    • 2.3.2 Qingdao Zhonghui Health Industrial Group Major Business
    • 2.3.3 Qingdao Zhonghui Health Industrial Group Medical Hemostatic Powders Product and Services
    • 2.3.4 Qingdao Zhonghui Health Industrial Group Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Qingdao Zhonghui Health Industrial Group Recent Developments/Updates
  • 2.4 Pfizer
    • 2.4.1 Pfizer Details
    • 2.4.2 Pfizer Major Business
    • 2.4.3 Pfizer Medical Hemostatic Powders Product and Services
    • 2.4.4 Pfizer Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Pfizer Recent Developments/Updates
  • 2.5 Success Bio-Tech
    • 2.5.1 Success Bio-Tech Details
    • 2.5.2 Success Bio-Tech Major Business
    • 2.5.3 Success Bio-Tech Medical Hemostatic Powders Product and Services
    • 2.5.4 Success Bio-Tech Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Success Bio-Tech Recent Developments/Updates
  • 2.6 Hangzhou Singclean Medical Products
    • 2.6.1 Hangzhou Singclean Medical Products Details
    • 2.6.2 Hangzhou Singclean Medical Products Major Business
    • 2.6.3 Hangzhou Singclean Medical Products Medical Hemostatic Powders Product and Services
    • 2.6.4 Hangzhou Singclean Medical Products Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hangzhou Singclean Medical Products Recent Developments/Updates
  • 2.7 Medtrade Products
    • 2.7.1 Medtrade Products Details
    • 2.7.2 Medtrade Products Major Business
    • 2.7.3 Medtrade Products Medical Hemostatic Powders Product and Services
    • 2.7.4 Medtrade Products Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Medtrade Products Recent Developments/Updates
  • 2.8 Beijing Tech-Bio-Med Medical Equipment
    • 2.8.1 Beijing Tech-Bio-Med Medical Equipment Details
    • 2.8.2 Beijing Tech-Bio-Med Medical Equipment Major Business
    • 2.8.3 Beijing Tech-Bio-Med Medical Equipment Medical Hemostatic Powders Product and Services
    • 2.8.4 Beijing Tech-Bio-Med Medical Equipment Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Beijing Tech-Bio-Med Medical Equipment Recent Developments/Updates
  • 2.9 Baxter (PerClot)
    • 2.9.1 Baxter (PerClot) Details
    • 2.9.2 Baxter (PerClot) Major Business
    • 2.9.3 Baxter (PerClot) Medical Hemostatic Powders Product and Services
    • 2.9.4 Baxter (PerClot) Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Baxter (PerClot) Recent Developments/Updates
  • 2.10 BioCer Entwicklungs
    • 2.10.1 BioCer Entwicklungs Details
    • 2.10.2 BioCer Entwicklungs Major Business
    • 2.10.3 BioCer Entwicklungs Medical Hemostatic Powders Product and Services
    • 2.10.4 BioCer Entwicklungs Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 BioCer Entwicklungs Recent Developments/Updates
  • 2.11 Hemostasis
    • 2.11.1 Hemostasis Details
    • 2.11.2 Hemostasis Major Business
    • 2.11.3 Hemostasis Medical Hemostatic Powders Product and Services
    • 2.11.4 Hemostasis Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Hemostasis Recent Developments/Updates
  • 2.12 Qingdao Biotemed Biomaterials
    • 2.12.1 Qingdao Biotemed Biomaterials Details
    • 2.12.2 Qingdao Biotemed Biomaterials Major Business
    • 2.12.3 Qingdao Biotemed Biomaterials Medical Hemostatic Powders Product and Services
    • 2.12.4 Qingdao Biotemed Biomaterials Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Qingdao Biotemed Biomaterials Recent Developments/Updates
  • 2.13 Aegis Lifesciences
    • 2.13.1 Aegis Lifesciences Details
    • 2.13.2 Aegis Lifesciences Major Business
    • 2.13.3 Aegis Lifesciences Medical Hemostatic Powders Product and Services
    • 2.13.4 Aegis Lifesciences Medical Hemostatic Powders Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Aegis Lifesciences Recent Developments/Updates

3 Competitive Environment: Medical Hemostatic Powders by Manufacturer

  • 3.1 Global Medical Hemostatic Powders Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Medical Hemostatic Powders Revenue by Manufacturer (2021-2026)
  • 3.3 Global Medical Hemostatic Powders Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Medical Hemostatic Powders by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Medical Hemostatic Powders Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Medical Hemostatic Powders Manufacturer Market Share in 2025
  • 3.5 Medical Hemostatic Powders Market: Overall Company Footprint Analysis
    • 3.5.1 Medical Hemostatic Powders Market: Region Footprint
    • 3.5.2 Medical Hemostatic Powders Market: Company Product Type Footprint
    • 3.5.3 Medical Hemostatic Powders Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Medical Hemostatic Powders Market Size by Region
    • 4.1.1 Global Medical Hemostatic Powders Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Medical Hemostatic Powders Consumption Value by Region (2021-2032)
    • 4.1.3 Global Medical Hemostatic Powders Average Price by Region (2021-2032)
  • 4.2 North America Medical Hemostatic Powders Consumption Value (2021-2032)
  • 4.3 Europe Medical Hemostatic Powders Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Medical Hemostatic Powders Consumption Value (2021-2032)
  • 4.5 South America Medical Hemostatic Powders Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Medical Hemostatic Powders Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Medical Hemostatic Powders Sales Quantity by Type (2021-2032)
  • 5.2 Global Medical Hemostatic Powders Consumption Value by Type (2021-2032)
  • 5.3 Global Medical Hemostatic Powders Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Medical Hemostatic Powders Sales Quantity by Application (2021-2032)
  • 6.2 Global Medical Hemostatic Powders Consumption Value by Application (2021-2032)
  • 6.3 Global Medical Hemostatic Powders Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Medical Hemostatic Powders Sales Quantity by Type (2021-2032)
  • 7.2 North America Medical Hemostatic Powders Sales Quantity by Application (2021-2032)
  • 7.3 North America Medical Hemostatic Powders Market Size by Country
    • 7.3.1 North America Medical Hemostatic Powders Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Medical Hemostatic Powders Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Medical Hemostatic Powders Sales Quantity by Type (2021-2032)
  • 8.2 Europe Medical Hemostatic Powders Sales Quantity by Application (2021-2032)
  • 8.3 Europe Medical Hemostatic Powders Market Size by Country
    • 8.3.1 Europe Medical Hemostatic Powders Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Medical Hemostatic Powders Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Medical Hemostatic Powders Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Medical Hemostatic Powders Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Medical Hemostatic Powders Market Size by Region
    • 9.3.1 Asia-Pacific Medical Hemostatic Powders Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Medical Hemostatic Powders Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Medical Hemostatic Powders Sales Quantity by Type (2021-2032)
  • 10.2 South America Medical Hemostatic Powders Sales Quantity by Application (2021-2032)
  • 10.3 South America Medical Hemostatic Powders Market Size by Country
    • 10.3.1 South America Medical Hemostatic Powders Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Medical Hemostatic Powders Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Medical Hemostatic Powders Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Medical Hemostatic Powders Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Medical Hemostatic Powders Market Size by Country
    • 11.3.1 Middle East & Africa Medical Hemostatic Powders Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Medical Hemostatic Powders Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Medical Hemostatic Powders Market Drivers
  • 12.2 Medical Hemostatic Powders Market Restraints
  • 12.3 Medical Hemostatic Powders Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Medical Hemostatic Powders and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Medical Hemostatic Powders
  • 13.3 Medical Hemostatic Powders Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Medical Hemostatic Powders Typical Distributors
  • 14.3 Medical Hemostatic Powders Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Medical Hemostatic Powders. Industry analysis & Market Report on Medical Hemostatic Powders is a syndicated market report, published as Global Medical Hemostatic Powders Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Medical Hemostatic Powders market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report